Beta Pharma Shanghai
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients (NCT03866499) | Beta Pharma Shanghai | 2021-04-30 |
| A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive (NCT03812809) | Beta Pharma Shanghai | 2019-07-05 |
| BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer (NCT03386955) | Beta Pharma Shanghai | 2017-08-16 |
Track Beta Pharma Shanghai automatically
Every clearance here is in the API, with alerts when new ones post.